Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Novabay Pharmaceuticals Inc’s current trading price is -96.23% away from its 52-week high, while its distance from the 52-week low is 3.38%. The stock’s price range during this period has varied between $0.07 and $1.95. The company, active in the Healthcare sector, saw a trading volume of around 3.76 million for the day, considerably higher average daily volume of 3.5 million observed over the last three months.
Novabay Pharmaceuticals Inc’s stock has had a tumultuous market performance. The 1-year high for the company’s stock was $1.95 on 04/24/23, and the lowest price during the same period was recorded at $0.07 on 04/22/24.
How Financial Performance Impacts Market Capitalization
Novabay Pharmaceuticals Inc (NBY) has experienced a quarterly decline of -52.88% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.65M and boasts a workforce of 26 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.1689, with a change in price of -0.2219. Similarly, Novabay Pharmaceuticals Inc recorded 2,728,071 in trading volume during the last 100 days, posting a change of -75.22%.
How NBY’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for NBY stands at 0.83. Similarly, the long-term debt-to-equity ratio is also 0.34.
NBY Stock Stochastic Average
As of today, the raw stochastic average of Novabay Pharmaceuticals Inc over the past 50 days is 7.70%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 9.53%. Additionally, the Stochastic %K and %D values for the company were 13.40% and 14.20%, respectively, over the past 20 days.
NBY Stock Price Performance Analysis
The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Year to date metric has recorded a loss of -63.97%.However, over the last six months, we can see a stronger performance of -80.14%. Over the last 30 days, the price of NBY has leaped by -46.43%. And in the last five days, it has fallen by -9.82%.
